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Abstract
The present study was designed to investigate the ameliorative potential of Ocimum sanctum and its saponin rich
fraction in vincristine-induced peripheral neuropathic pain in rats. Peripheral neuropathy was induced in rats by
administration of vincristine sulfate (50 μg/kg i.p.) for 10 consecutive days. The mechanical hyperalgesia, cold allo-
dynia, paw heat hyperalgesia and cold tail hyperalgesia were assessed by performing the pinprick, acetone, hot
plate and cold tail immersion tests, respectively. Biochemically, the tissue thio-barbituric acid reactive species
(TBARS), super-oxide anion content (markers of oxidative stress) and total calcium levels were measured. Vincristine
administration was associated with the development of mechanical hyperalgesia, cold allodynia, heat and cold
hyperalgesia. Furthermore, vincristine administration was also associated with an increase in oxidative stress and
calcium levels. However, administration of Ocimum sanctum (100 and 200 mg/kg p.o.) and its saponin rich fraction
(100 and 200 mg/kg p.o.) for 14 days significantly attenuated vincristine-induced neuropathic pain along with
decrease in oxidative stress and calcium levels. It may be concluded that Ocimum sanctum has ameliorative poten-
tial in attenuating chemotherapy induced-painful neuropathic state, which may be attributed to decrease in oxida-
tive stress and calcium levels. Furthermore, saponin rich fraction of Ocimum sanctum may be responsible for its
noted beneficial effect in neuropathic pain in rats.
Introduction
Neuropathic pain has been described as “the most terri-
ble of all tortures which a nerve wound may inflict” [1].
Despite progress in the understanding of this syndrome,
the mechanistic details underlying the disease remain
elusive. Neuropathic pain is generally characterized by
the sensory abnormalities such as unpleasant abnormal
sensation (dysesthesia), an increased response to painful
stimuli (hyperalgesia), andp a i ni nr e s p o n s et oas t i m u -
lus that does not normally provoke pain (allodynia) [2].
Peripheral neuropathic pain is frequently observed in
patients with cancer, AIDS, long standing diabetes, lum-
bar disc syndrome, herpes infection, traumatic spinal
cord injury, multiple sclerosis and stroke [3]. Moreover,
post-thoracotomy, post-herniorrhaphy, post-mastectomy
and post-sternotomy are some other conditions often
associated with peripheral neuropathy pain [4].
Chemotherapeutic drugs such as vincristine, paclitaxel,
oxaliplatin, etc. are widely used in management of can-
cers especially Hodgkins lymphoma, non-Hodgkins
lymphoma and leukemia. Unfortunately, these anti-can-
cer agents have been documented to produce dose and
duration dependent neurotoxicity and painful neuropa-
thy [5] which limit their full exploitation in the manage-
ment of tumors. Vincristine is unique among the
chemotherapeutic agents that it produces predictably
and uniformly neurotoxicity in all the patients even at
the therapeutic doses [6]. This peripheral neuropathy is
dose-related with a marked variability in individual sus-
ceptibility. After stopping vincristine administration,
partial or complete clinical recovery follows which takes
several months.
Though some drugs have been found to be effective in
managing the symptoms of neuropathy, yet their full
clinical exploitation is limited due to wide spectrum of
adverse effects associated with their clinical use. More-
over, none of the medications, assessed in randomized
controlled studies conducted, has been found to be
effective in injury induced and chemotherapy-induced
neuropathic pain [7]. Therefore, there has been an
urgent need of alternative medicine for managing neuro-
pathy particularly in injury and chemotherapy-induced * Correspondence: nirmal_puru@rediffmail.com
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look back at the traditional medicines.
Ocimum sanctum (L.), (syn, Tulsi) is an indigenous
plant commonly found in India and is recommended in
the Ayurveda for the treatment of bronchial asthma,
malaria, dysentery, skin diseases, arthritis, painful eye
diseases, chronic fever and insect bite. Experimental
reports have indicated its protective effects against geno-
toxicants, chemical carcinogens, ischaemic cerebral
injury [8], ischaemia-reperfusion and isoproterenol-
induced myocardial damage. Moreover, its anti-convul-
sant [9], hepato-protective, immuno-modulatory, anti-
ulcer, anti-diabetic, anti-hypercholesterolaemic, chemo-
protective, nootropic, antitussive, anti-inflammatory,
wound healing, anti-tumorigenesis, anthelmintic, anti-
bacterial, anti-giardial [10], anti-anxiety [11], and anti-
stress activities have also been documented. Tradition-
ally, Ocimum sanctum has been used as nerve tonic and
to alleviate joint pain, headache and muscular pain par-
ticularly in South India. Recently, from our laboratory it
has been documented that Ocimum sanctum has ameli-
orative potential in attenuating sciatic nerve transection-
induced neuropathic pain [12].
Saponins are important phyto-constituents present in
different plants including Ocimum sanctum in which
these constitute an important chemical class and include
pentacyclic triterpenoids saponins such as ursolic acid,
oleanolic acid [13,14]. Number of studies have shown
that saponins exert diverse biological actions such as
anti-hypertensive [15], anti-cancer [16], anti-convulsant
[17], anti-diabetic [18], anti-amnestic [19], hypocholes-
terolaemic [20] and neuroprotective [21]. Furthermore,
saponins have also been shown to exhibit anti-nocicep-
tive actions [22,23]; alleviate neuropathic pain in long
standing diabetes [24] and nerve entrapment induced
facial paralysis (Bell’s palsy) [25].
The present study was designed to investigate the
ameliorative role of Ocimum sanctum in vincristine-
induced neuropathy and to further explore the contribu-
tory role of saponins in Ocimum sanctum mediated ben-
eficial effect in neuropathic pain in rats.
Materials and methods
Experimental Animals
Wistar albino rats weighing 180-250 g, maintained on
standard laboratory diet (Kisan Feeds Ltd., Mumbai,
India) and having free access to tap water were
employed in the present study. They were housed in the
departmental animal house and were exposed to normal
cycle of light and dark. The experimental protocol was
approved by the Institutional Animal Ethics Committee
(IAEC) and the care of the animals was carried out as
per the guidelines of the Committee for the Purpose of
Control and Supervision of Experiments on Animals
(CPCSEA), Ministry of Environment and Forest, Gov-
ernment of India (Reg. No- 107/1999/CPCSEA).
Drugs and Chemicals
Vincristine sulfate (Chandra Bhagat Pharma Pvt. Ltd.,
Mumbai), was dissolved in normal saline. All the
reagents used in the present study were of analytical
grade.
Plant material
Fresh leaves of Ocimum sanctum were collected from
Patiala and authenticated through Botany Department,
Punjabi University, Patiala. The Plant sample has been
kept in Voucher specimen (PUP-039/2008-2009) at Pun-
jabi university, Patiala. The fresh leaves of Ocimum sanc-
tum were shed dried at room temperature and reduced
to coarse powder. The powder was extracted with mix-
ture of methanol: water (3:1). The solvent was completely
removed at 50°C under reduced pressure. The yield of
the extract was 13% (w/w) in terms of dried starting
material. The extract was standardized using HPTLC fin-
ger-printing taking chloroform and methanol (80:20) as
mobile phase and using anisaldehyde sulphuric acid as
spraying agent. The bands were detected at 254 nm, 366
nm and under white light (Table 1). The saponin rich
fraction was extracted from the concentrated hydro-alco-
holic extract as described earlier [26,27]. Briefly, the
hydro-alcoholic extract was decanted by n-hexane fol-
lowed by extraction with n-butanol. After three succes-
sive extractions with n-butanol, the resulting solutions
were combined and the butanol was completely removed
at 50°C under reduced pressure to collect the residue
rich in saponin. The saponins were identified using froth
test and triterpenoid saponins were identified using Lie-
berman-Burchard test.
Induction of Neuropathic Pain by Vincristine
Peripheral neuropathy was induced in rats by adminis-
tration of vincristine sulfate (50 μg/kg i.p.) for 10 conse-
cutive days as described previously [28].
Behavioral Examination
Paw Cold-Allodynia (Acetone Drop Test)
The cold allodynia was assessed by spraying a 100 μLo f
acetone onto the planter surface of the paw, without
touching the skin. The duration of withdrawal response
was recorded with an arbitrary minimum value of 0.5 s
and a maximum value of 20 s [29].
Paw Heat-Hyperalgesia (Hot Plate Test)
The thermal nociceptive threshold, as an index of ther-
mal hyperalgesia, was assessed by the Eddy’s hot plate,
which is an instrument designed by Eddy and co-work-
ers to assess thermal sensitivity. The plate was pre-
heated and maintained at a temperature of 52.5 ± 2.0°C.
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threshold, with respect to licking of the hind paw, was
recorded in seconds. The cut-off time of 20 s was main-
tained [30].
Mechanical hyperalgesia: (Pin prick test)
The mechanical hyperalgesia was assessed by the pin-
prick test as described by Erichsen and Blackburn-
Munro [31]. The surface of the injured hind paw was
touched with the point of the bent gauge needle (at 90°
to the syringe) at intensity sufficient to produce a reflex
withdrawal response in normal non-operated animals,
but at an intensity which was insufficient to penetrate
the skin. The duration of the paw withdrawal was
recorded in seconds with a stopwatch. A cut-off time of
20 s was maintained.
Tail Cold-Hyperalgesia Test (Tail Immersion Test)
The tail cold-hyperalgesia was noted by immersing a
terminal part of the tail (1 cm) in the water, maintained
at a temperature of 0-4°C. The tail withdrawal latency
was recorded and a cut-off time of 20 s was maintained
[32].
Biochemical Estimation
All the groups of animals were sacrificed after 14
th day
by cervical dislocation and the sciatic nerve was isolated
immediately [30,33]. The uniformity among the different
nerve samples was maintained by taking the constant
weight of the respective samples. The excised sciatic
nerve homogenate (10% w/v) was prepared with 0.1 M
Tris- HCl buffer (pH 7.4). The tubes with homogenate
were kept in ice water for 30 minutes and centrifuged at
4°C (2500 rpm, 10 min). The supernatant of homoge-
nate was separated, and employed to estimate total pro-
tein content, TBARS, superoxide anion concenteration
and total calcium content.
Estimation of the protein content
The protein concentration in the sciatic nerve was esti-
mated according to the method of Lowry et al.,[ 3 4 ]
using bovine serum albumin as a standard. The absor-
bance was determined spectrophotometrically at 750
nm.
Estimation of thio-barbituric acid reactive substances
The estimation of lipid peroxidation in the sciatic nerve
was done by measuring the thio-barbituric acid reactive
substances by the method of Okhawa et al.[ 3 5 ] .T h e
absorbance was measured spectrophotometrically at 532
nm. The concentration was expressed in terms of nmol
of thio-barbituric acid reactive substances/mg protein.
2.6.3. Estimation of superoxide anion generation
The superoxide anion generation in the sciatic nerve
was estimated in terms of measuring reduced nitroblue
tetrazolium (NBT) [36]. The absorbance of formazan
was determined spectrophotometerically at 540 nm.
Estimation of total calcium
The total calcium levels were estimated in the sciatic
nerve as described earlier [33,37]. Briefly, the sciatic
nerve homogenate was mixed with 1 ml of trichloroace-
tic acid (4%) in ice cold conditions and centrifuged at
1500 g, for 10 minutes. The clear supernatant was used
for the estimation of total calcium ion by atomic emis-
sion spectroscopy at 556 nm.
Experimental Protocol
Nine groups, each group comprising six Wistar albino
rats, were employed in the present study.
Group I: Normal control group
Rats were not subjected to any treatment and were kept
for 14 days. The behavioral tests were employed on dif-
ferent days i.e., day 2
nd,6
th,8
th and 14
th. All the animals
were sacrificed at end of the 14
th day and the biochem-
ical analysis was done for estimation of protein content,
TBARS, superoxide anion and total calcium.
Group II: Vincristine control group
Vincristine (50 μg/kg, i.p.) was administered to normal
rats for 10 consecutive days (1-10). The behavioral tests
were assessed starting on days 2
nd,6
th,8
th and 14
th.A t
the end of 14
th day, the animals were sacrificed and bio-
chemical analysis was done as described in group I.
Group III: Vehicle in vincristine control group
Rats were administered carboxymethylcellulose suspen-
sion (0.5% w/v, p.o.) 2 h before each vincristine injec-
tion, for 14 consecutive days (1-14). The behavioral tests
and biochemical parameters were assessed as mentioned
in group I.
Group IV: Hydro-alcoholic extract of Ocimum sanctum per
se
The hydro-alcoholic extract of Ocimum sanctum (200
mg/kg p.o.) was administered to normal rats for 14 con-
secutive days, starting from the day one. The behavioral
tests and the biochemical parameters were assessed as
described in group I.
Group V: Saponin rich extract of Ocimum sanctum per se
The saponin rich extract of Ocimum sanctum (200 mg/
kg p.o.) was administered to normal rats for 14 consecu-
tive days, starting from the day one. The behavioral
Table 1 HPTLC fingerprinting of hydro-alcholic extract of
Ocimum sanctum taking chloroform and methanol (80:20)
as mobile phase and using anisaldehyde as spraying
agent. The values indicate the Rf values of the separated
bands.
S. No of Resolving Bands UV 254 nm UV 366 Under white light
1. - - 0.44
2. - - 0.60
3. - - 0.71
4. - - 0.78
5. - - 0.85
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described in group I.
Group VI and VII: Hydro-alcoholic extract of Ocimum
sanctum (100; 200 mg/kg p.o.) in vincristine control group
The hydro-alcoholic extract of Ocimum sanctum (100;
200 mg/kg p.o.) was administered for 14 consecutive
days, starting from the day one, 2 h prior to vincristine
administration. The behavioral tests and the biochemical
parameters were assessed as described in group I.
Group VIII and IX: Saponin rich fraction of Ocimum
sanctum (100; 200 mg/kg p.o.) in vincristine control group
The saponin rich fraction of Ocimum sanctum (100 and
200 mg/kg p.o.) was administered for 14 consecutive
days, starting from the day one, 2 h prior to vincristine
administration. The behavioral tests and the biochemical
parameters were assessed as described in group I.
Statistical Analysis
All the results were expressed as mean ± standard error
mean (S.E.M.). The data of behavioral results was statis-
tically analyzed by two-way ANOVA followed by Bon-
feronni’s post test by using Graph pad prism Version-
5.0 software. The data of biochemical results was statis-
tically analyzed by one-way ANOVA followed by
Tukey’s multiple range test by using Sigmastat Version-
2.0 software. The p-value < 0.05 was considered to be
statistically significant.
Results
Effect of Ocimum sanctum and its Saponin Rich Fraction
on Cold Allodynia in Neuropathic Pain
Vincristine administration resulted in the development of
cold allodynia as reflected by an increase in the duration
of hind paw withdrawal, when compared to normal con-
trol group. However, pre-treatment with Ocimum sanc-
tum (100 and 200 mg/kg p.o.) and its saponin rich
fraction (100 and 200 mg/kg p.o.) significantly attenuated
vincristine-induced increase in the withdrawal duration
of the hind paw in response to non-noxious cold stimuli.
T h ee f f e c to fs a p o n i nr i c hf r a c t i o ni na t t e n u a t i n gc o l d
allodynia was significantly higher than the hydro-alco-
holic extract at the same dose levels (Figure 1). Vehicle
administration did not modulate the behaviour in
response to non-noxious cold stimulus in animals sub-
jected to peripheral neuropathy. Per se administration of
Ocimum sanctum and its saponin rich fraction also did
not produce alterations in the normal rats.
Effect of Ocimum sanctum and its saponin rich fraction
on mechanical hyperalgesia in Neuropathic Pain
Vincristine administration was associated with the devel-
opment of mechanical hyperalgesia as reflected by an
increase in the hind paw withdrawal duration, when
compared to normal control group. Treatment with
Ocimum sanctum (100 and 200 mg/kg p.o.)a n di t s
saponin rich fraction (100 and 200 mg/kg p.o.)s i g n i f i -
cantly attenuated vincristine-induced increase in with-
drawal duration of the hind paw in response to noxious
mechanical stimuli. The effect of saponin rich fraction
in attenuating mechanical hyperalgesia was significantly
higher than the hydro-alcoholic extract at the same dose
levels (Figure 2). Vehicle administration did not modu-
late behaviour in response to noxious mechanical stimu-
lus in animals subjected to peripheral neuropathy. Per se
administration of Ocimum sanctum and its saponin rich
fraction also did not produce alterations in the normal
rats.
Effect of Ocimum sanctum and its saponin rich fraction
on paw heat and cold tail hyperalgesia in Neuropathic
Pain
Vincristine administration led to the development of
paw heat and tail cold hyperalgesia as reflected by
decrease in the withdrawal threshold of the hind paw
and tail respectively, when compared to normal control
group. However, treatment with Ocimum sanctum (100
and 200 mg/kg p.o.) and its saponin rich fraction (100
and 200 mg/kg p.o.) significantly attenuated vincristine-
induced decrease in the withdrawal latency in response
to noxious thermal stimuli. The effect of saponin rich
fraction in attenuating thermal hyperalgesia was signifi-
cantly higher than the hydro-alcoholic extract at the
same dose levels (Figures 3 and 4). Vehicle administra-
tion did not modulate behaviour in response to noxious
thermal stimulus in animals subjected to peripheral neu-
ropathy. Per se administration of Ocimum sanctum and
its saponin rich fraction also did not produce alterations
in the normal rats.
Effect of Ocimum sanctum and its saponin rich fraction
on oxidative stress markers and total calcium content in
Neuropathic Pain
Vincristine administration resulted in an increase in the
oxidative stress markers and total calcium content as
reflected by an increase in the tissue thio-barbituric acid
reactive substances, superoxide anion content and total
calcium levels, when compared to normal control group.
However, treatment with Ocimum sanctum (100 and
200 mg/kg p.o.) and its saponin rich fraction (100 and
200 mg/kg p.o.) significantly attenuated the vincristine-
induced increase in oxidative stress markers and total
calcium levels. The effect of saponin rich fraction in
attenuating the rise in the levels of oxidative stress mar-
kers and the calcium levels was significantly higher than
the hydro-alcoholic extract at the same dose levels.
Vehicle administration did not modulate alterations in
the levels of oxidative stress markers and total calcium
content in animals subjected to peripheral neuropathy.
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nin rich fraction also did not produce any biochemical
alterations in the normal rats (Table 2).
Discussion
In the present investigation, vincristine (50 μg/kg, i.p.)
administration for 10 days led to significant develop-
ment of cold allodynia, mechanical, tail cold and paw
heat hyperalgesia. The observed behavioral alterations in
this study are in consistent with the earlier reports doc-
umenting the development of pain symptoms with vin-
cristine administration [28,33]. Vincristine has been
widely employed for the management of number of can-
cers including Hodgkin’s disease. However, its clinical
application has been limited due to unavoidable painful
sensorimotor neuropathy, observed in about half of the
patients on vincristine treatment. Clinically, the neuro-
pathy is characterized by paresthesias in hand and feet
and the pinprick and thermal senses are more affected
than vibration senses. Binding of vincristine to b-tubulin
with subsequent disruption of microtubules has been
documented for its anti-tumor actions and the same is
also assumed to produce neuro-toxicity by axonal
degeneration.
However, pretreatment with Ocimum sanctum signifi-
cantly attenuated vincristine-induced alterations in pain
perception in response to noxious as well as non-nox-
ious stimuli, suggesting that Ocimum sanctum may be
employed to limit the painful symptoms associated with
chemotherapy treatment. Traditionally, Ocimum sanc-
tum has been used as a nerve tonic to alleviate disorders
related to nerves. Recently, it has been reported from
our laboratory that Ocimum sanctum attenuates the
neuropathic pain in sciatic nerve transection model [12].
Ocimum sanctum i sar i c hs o u r c eo fan u m b e ro f
saponins and the most important of them are ursolic
acid and oleanolic acid. These saponins have been
reported to possess beneficial effects in number of disor-
ders such as in amnesia [38], hypertension [39], myocar-
dial ischemia [40], and cancer [41]. Furthermore, the
saponins have also shown the beneficial effects in reliev-
ing nociceptive pain [22,23] as well as neuropathic pain
in diabetes [24] and facial paralysis (Bell’sp a l s y )d u et o
nerve entrapment [25]. Therefore, to explore the chemi-
cal class of Ocimum sanctum responsible of its benefi-
cial effect its saponin rich fraction was evaluated in
neuropathic pain. In the present investigation, pre-treat-
ment with the saponin rich fraction of Ocimum sanctum
Figure 1 Effect of Ocimum sanctum and its saponin rich fraction on cold allodynia in vincristine-induced neuropathic pain.V i n . :
vincristine; O.s.: Ocimum sanctum; Sap.: saponin rich extract of Ocimum sanctum. Data were expressed as mean ± S.E.M., n = 6 rats per group. a
= p < 0.05 Vs normal control group, b = p < 0.05 Vs vincristine control group, c = p < 0.05 Vs Ocimum sanctum 100 and 200 mg/kg group, d =
p < 0.05 Vs saponin rich fraction 100 mg/kg group.
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Page 5 of 9Figure 2 Effect of Ocimum sanctum and its saponin rich fraction on mechanical hyperalgesia in vincristine-induced neuropathic pain.
Vin.: vincristine, O.s.: Ocimum sanctum, Sap.: saponin rich extract of Ocimum sanctum. Data were expressed as mean ± S.E.M., n = 6 rats per
group. a = p < 0.05 Vs normal control group, b = p < 0.05 Vs vincristine control group, c = p < 0.05 Vs Ocimum sanctum 100 and 200 mg/kg
group, d = p < 0.05 Vs saponin rich fraction 100 mg/kg group.
Figure 3 Effect of Ocimum sanctum and its saponin rich fraction on paw heat hyperalgesia in vincristine-induced neuropathic pain.
Vin.: vincristine, O.s.: Ocimum sanctum, Sap.: saponin rich extract of Ocimum sanctum. Data were expressed as mean ± S.E.M., n = 6 rats per
group. a = p < 0.05 Vs normal control group, b = p < 0.05 Vs vincristine control group, c = p < 0.05 Vs Ocimum sanctum 100 and 200 mg/kg
group, d = p < 0.05 Vs saponin rich fraction 100 mg/kg group.
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neuropathic pain. Therefore, it may be proposed that
saponins are the principal components responsible for
the noted beneficial effects of Ocimum sanctum in neu-
ropathic pain.
Furthermore, in this study vincristine administration
was associated with the rise in the oxidative stress (rise
in thio-barbituric acid reactive substances and superox-
ide anion content) and total calcium content. It has also
been documented that oxidative stress and an increase
in calcium levels play a critical role in chemotherapy
associated neuropathic pain including vincristine
[28,33,42]. However, treatment with Ocimum sanctum
and its saponin rich fraction attenuated vincristine asso-
ciated increase in oxidative stress and calcium levels.
Ocimum sanctum has a well documented antioxidant
effect [10,43] and also decreases the calcium levels [12].
Free radicals have been well documented to increase
calcium levels [44,45]. Therefore, the observed decrease
in calcium levels with Ocimum sanctum m a yp o s s i b l yb e
Figure 4 Effect of Ocimum sanctum and its saponin rich fraction on tail cold hyperalgesia in vincristine-induced neuropathic pain. Vin.:
vincristine, O.s.: Ocimum sanctum, Sap.: saponin rich extract of Ocimum sanctum. Data were expressed as mean ± S.E.M., n = 6 rats per group. a
= p < 0.05 Vs normal control group, b = p < 0.05 Vs vincristine control group, c = p < 0.05 Vs Ocimum sanctum 100 and 200 mg/kg group.
Table 2 Effect of Ocimum sanctum and its saponin rich fraction on thio-barbituric acid reactive substances, superoxide
anion content and total calcium in vincristine-induced neuropathic pain.
Groups Doses Total Protein
(mg/g of
tissue)
TBARS
(nmol/mg of
protein)
Superoxide Anion
Content
(pmol/min/mg of protein)
Total Calcium
(ppm/mg of
protein)
Normal Control - 5.17 ± 0.23 5.97 ± 0.26 0.15 ± 0.02 4.97 ± 0.21
Vincristine Control - 5.36 ± 0.13 8.28 ± 0.24
a 0.79 ± 0.05
a 32.20 ± 0.18
a
Vehicle in Vincristine Control - 5.29 ± 0.17 8.24 ± 0.22
a 0.81 ± 0.03
a 32.02 ± 0.16
a
Ocimum sanctum per se 200 mg/
kg
5.21 ± 0.15 6.00 ± 0.28 0.16 ± 0.01 5.09 ± 0.15
Saponin rich fraction per se 200 mg/
kg
5.30 ± 0.14 6.06 ± 0.24 0.14 ± 0.02 4.92 ± 0.17
Ocimum sanctum in vincristine control 100 mg/
kg
5.33 ± 0.22 7.56 ± 0.16
a, b 0.56 ± 0.02
a, b 29.5 ± 0.18
a, b
Ocimum sanctum in vincristine control 200 mg/
kg
5.26 ± 0.16 7.52 ± 0.15
a, b 0.54 ± 0.03
a, b 29.8 ± 0.20
a, b
Saponin rich fraction in vincristine
control
100 mg/
kg
5.35 ± 0.13 6.90 ± 0.19
a, b, c 0.38 ± 0.04
a, b, c 21.1 ± 0.19
a, b, c
Saponin rich fraction in vincristine
control
200 mg/
kg
5.29 ± 0.14 6.28 ± 0.21
a, b, c, d 0.25 ± 0.02
a, b, c, d 12.2 ± 0.13
a, b, c, d
Data were expressed as mean ± S.E.M., n = 6 rats per group a = p < 0.05 Vs normal control group, b = p < 0.05 Vs vincristine control group, c = p < 0.05 Vs
Ocimum sanctum100 and 200 mg/kg group, d = p < 0.05 Vs saponin rich fraction 100 mg/kg group.
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be possible that direct action of Ocimum sanctum is
responsible for the observed decrease in the calcium
levels. Therefore, the observed decrease in calcium levels
due to Ocimum sanctum m a yb ee i t h e rd u et od i r e c t
action or secondary to decrease in oxidative stress. How-
ever, data of the present study is still insufficient to ela-
borate the precise mechanism of Ocimum sanctum
mediated decrease in calcium levels. Furthermore, sapo-
nins have also been reported to decrease oxidative stress
[46] and calcium levels [47-49]. Based on these, it may be
proposed that Ocimum sanctum has potential in amelior-
ating the painful symptoms in vincristine-induced per-
ipheral neuropathy and saponins may be the principal
chemical class responsible for its beneficial effect in neu-
ropathic pain. Furthermore, the pain relieving effects of
Ocimum sanctum and its saponin rich fraction may be
due to attenuation of nerve injury inciting agent-induced
increased levels of calcium and free radicals.
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